The acquisition combines institutional AI and alternative data processing to deliver the industry’s first fully integrated wealth intelligence solution. NEW YORK, Feb. 19, 2026 /PRNewswire/ — BridgeWise, the global leader in AI for wealth, today announced the acquisition of Chicago-based Context Analytics, the top AI-powered alternative data processing company, used by tier-one financial firms including […]
Category Archives: Pr Newswire
Japan’s Ministry of Health, Labour and Welfare (MHLW) Approves PreemieFort® Enteral Solution as Prescription Medicine in the NICU DUARTE, Calif., Feb. 19, 2026 /PRNewswire/ — Prolacta Bioscience® today announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved PreemieFort® Enteral Solution, a 100% human milk-based fortifier, as a prescription drug for very low birth weight infants, infants with congenital gastrointestinal disorders or congenital heart diseases, and those recovering from gastrointestinal surgery. This regulatory milestone […]
SHENZHEN, China, Feb. 19, 2026 /PRNewswire/ — MicroCloud Hologram Inc. (NASDAQ: HOLO), (“HOLO” or the “Company”), a technology service provider, proposed a quantum intelligent interconnected fault-tolerant consensus algorithm that deeply integrates quantum computing technology into the consensus mechanism, achieving dynamic automatic access and secure exit of financial internet nodes in edge computing networks. This not only […]
NORWALK, Conn., Feb. 19, 2026 /PRNewswire/ — Lifespan Vision Ventures, an investment firm focused on therapeutics that improve human healthspan, today announced that it has co-led Sift Biosciences’ oversubscribed $3.7 million Pre-Seed financing alongside Freeflow Ventures, with participation from Valuence Ventures, Eisai Innovation, SBI US Gateway Fund, and other early investors. Sift Biosciences is developing […]
HONG KONG, Feb. 18, 2026 /PRNewswire/ — Tonight (18 February) Hong Kong celebrated the arrival of the Chinese New Year with the spectacular “Prosperity Gallops Across Hong Kong” Year of the Horse Fireworks Display, exclusively sponsored by The Hong Kong Jockey Club (the Club). Meanwhile, there was a drone and fireworks show in Conghua, Guangzhou, also […]
Pr Newswire
BrainsWay Reports Cigna’s Evernorth Behavioral Health to Eliminate Prior Authorization Requirements for TMS Coverage, Accelerating Access to Care
18
Feb
Feb
BURLINGTON, Mass. and JERUSALEM, Feb. 18, 2026 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation technologies, today commented on the recent news issued by Evernorth® Behavioral Health, Inc., a division of the Cigna Group, which serves over 18 million covered lives across 12 […]
18
Feb
Feb
NORTHFIELD, Ill., Feb. 18, 2026 (GLOBE NEWSWIRE) — Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that Jim Boyle, Chief Executive Officer, and Mike Drazin, Chief Financial Officer, are scheduled to present at the Barclays 28th Annual Global Healthcare Conference in Miami Beach, FL, on Wednesday, March 11, 2026, at 9:30am ET. A webcast of the […]
18
Feb
Feb
TORONTO and HOUSTON, Feb. 18, 2026 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines targeting cancer, autoimmune, and inflammatory diseases is pleased to announce its participation in several upcoming conferences. These events provide an opportunity for Medicenna to showcase […]
Pr Newswire
Crescent Biopharma Announces First Patient Dosed in ASCEND Phase 1/2 Clinical Trial of CR-001 for the Treatment of Advanced Solid Tumors
18
Feb
Feb
ASCEND to evaluate CR-001, a PD-1 x VEGF bispecific antibody, in multiple solid tumor types, including NSCLC and gastrointestinal and gynecological cancers in first-line and previously treated patients Company anticipates reporting proof-of-concept data in the first quarter of 2027 ASCEND is the first of four clinical trials across the portfolio expected to initiate in 2026 […]
18
Feb
Feb
VANCOUVER, British Columbia, Feb. 18, 2026 (GLOBE NEWSWIRE) — NervGen Pharma Corp. (“NervGen” or the “Company”) (TSXV: NGEN) (NASDAQ: NGEN), a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions, today announced that Adam Rogers, MD, President and Chief Executive Officer of NervGen, and other members […]